Have access already?

Get access to this article:

Or get access to the particular issue:

Or get access to the entire journal:

Advertisement

Abstract

Apnea of prematurity is a common problem of the premature infant under 30 weeks gestation. Theophylline and caffeine, two methylxanthines, are widely used to treat this condition. The drugs are equally effective in preventing apnea in the premature infant. Caffeine citrate has many advantages over theophylline, however, including once-aday dosing, more predictable plasma concentrations, earlier onset of action, and minimal side effects. Caffeine is therefore the initial drug of choice for apnea of prematurity.

Article usage
Article Usage
Period Abstract Full PDF Total
Jan 2022 22 0 0 22
Dec 2021 33 0 0 33
Nov 2021 28 0 0 28
Oct 2021 21 0 2 23
Sep 2021 7 0 0 7
Aug 2021 8 0 0 8
Jul 2021 4 0 0 4
Jun 2021 12 0 0 12
May 2021 7 0 1 8
Apr 2021 31 0 1 32
Mar 2021 30 0 0 30
Feb 2021 8 0 0 8
Jan 2021 11 0 0 11
Dec 2020 24 0 1 25
Nov 2020 16 0 0 16
Oct 2020 14 0 0 14
Sep 2020 23 0 2 25
Aug 2020 32 0 3 35
Jul 2020 31 0 0 31
Jun 2020 36 0 0 36
May 2020 30 0 1 31
Apr 2020 11 0 0 11
Mar 2020 15 0 0 15
Feb 2020 25 0 0 25
Jan 2020 18 0 0 18
Dec 2019 14 0 0 14
Nov 2019 17 0 2 19
Oct 2019 18 0 0 18
Sep 2019 19 0 0 19
Aug 2019 18 0 1 19
Jul 2019 13 0 0 13
Jun 2019 14 0 0 14
May 2019 8 0 0 8
Apr 2019 9 0 0 9
Mar 2019 7 0 0 7
Feb 2019 16 0 0 16
Jan 2019 4 0 1 5
Dec 2018 7 0 2 9
Nov 2018 10 0 1 11
Oct 2018 11 0 2 13
Aug 2018 6 0 0 6
Jul 2018 5 0 2 7